Non-neuronal functions of the M2 muscarinic acetylcholine receptor

Genes

Volumn 4, Issue 2, 2013, Pages 171-197

  Ockenga, Wymke ^a   Kühne, Sina ^a   Bocksberger, Simone ^a   Banning, Antje ^a   Tikkanen, Ritva ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Acetylcholine; G proteins; Muscarinic receptors; Signal transduction

Indexed keywords

ACETYLCHOLINE; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 6; CD4 ANTIGEN; CD8 ANTIGEN; G PROTEIN COUPLED RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR; NICOTINIC RECEPTOR;

AUTOIMMUNE DISEASE; BLADDER CONTRACTION; BREAST CANCER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; ENDOCYTOSIS; EPITHELIUM CELL; GLIOBLASTOMA; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INTERNALIZATION; LIVER CELL CARCINOMA; LUNG SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; MUCOCILIARY CLEARANCE; NONHUMAN; PARASYMPATHETIC FUNCTION; PERMEABILITY BARRIER; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RESPIRATORY EPITHELIUM; REVIEW; SIGNAL TRANSDUCTION; SKIN EPITHELIUM; TUMOR INVASION; TUMOR VASCULARIZATION;

EID: 84877911058     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes4020171     Document Type: Review

References (170)

1. Bennett, M.R. The concept of transmitter receptors: 100 years on. Neuropharmacology 2000, 39, 523-546.
2. Curtis, D.R.; Ryall, R.W. Nicotinic and Muscarinic Receptors of Renshaw Cells. Nature 1964, 203, 652-653.
3. Kurzen, H.; Wessler, I.; Kirkpatrick, C.J.; Kawashima, K.; Grando, S.A. The non-neuronal cholinergic system of human skin. Horm. Metab. Res. 2007, 39, 125-135.
4. Bonner, T.I.; Buckley, N.J.; Young, A.C.; Brann, M.R. Identification of a family of muscarinic acetylcholine receptor genes. Science 1987, 237, 527-532.
5. Caulfield, M.P.; Birdsall, N.J. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev. 1998, 50, 279-290.
6. Hall, J.M.; Caulfield, M.P.; Watson, S.P.; Guard, S. Receptor subtypes or species homologues: relevance to drug discovery. Trends Pharmacol. Sci. 1993, 14, 376-383.
7. Jones, S.V.; Heilman, C.J.; Brann, M.R. Functional responses of cloned muscarinic receptors expressed in CHO-K1 cells. Mol. Pharmacol. 1991, 40, 242-247.
8. Alea, M.P.; Borroto-Escuela, D.O.; Romero-Fernandez, W.; Fuxe, K.; Garriga, P. Differential expression of muscarinic acetylcholine receptor subtypes in Jurkat cells and their signaling. J. Neuroimmunol. 2011, 237, 13-22.
9. Nahorski, S.R.; Tobin, A.B.; Willars, G.B. Muscarinic M3 receptor coupling and regulation. Life Sci. 1997, 60, 1039-1045.
10. Hulme, E.C.; Lu, Z.L.; Saldanha, J.W.; Bee, M.S. Structure and activation of muscarinic acetylcholine receptors. Biochem. Soc. Trans. 2003, 31, 29-34.
11. Nathanson, N.M. A multiplicity of muscarinic mechanisms: Enough signaling pathways to take your breath away. Proc. Natl. Acad. Sci. USA 2000, 97, 6245-6247.
12. Hayashi, M.K.; Haga, T. Palmitoylation of muscarinic acetylcholine receptor m2 subtypes: Reduction in their ability to activate G proteins by mutation of a putative palmitoylation site, cysteine 457, in the carboxyl-terminal tail. Arch. Biochem. Biophys. 1997, 340, 376-382.
13. Shah, N.; Khurana, S.; Cheng, K.; Raufman, J.P. Muscarinic receptors and ligands in cancer. Am. J. Physiol. Cell. Physiol. 2009, 296, C221-C232.
14. Gomeza, J.; Shannon, H.; Kostenis, E.; Felder, C.; Zhang, L.; Brodkin, J.; Grinberg, A.; Sheng, H.; Wess, J. Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice. Proc. Natl. Acad. Sci. USA 1999, 96, 1692-1697.
15. Gomeza, J.; Zhang, L.; Kostenis, E.; Felder, C.; Bymaster, F.; Brodkin, J.; Shannon, H.; Xia, B.; Deng, C.; Wess, J. Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice. Proc. Natl. Acad. Sci. USA 1999, 96, 10483-10488.
16. Miyakawa, T.; Yamada, M.; Duttaroy, A.; Wess, J. Hyperactivity and intact hippocampusdependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J. Neurosci. 2001, 21, 5239-5250.
17. Yamada, M.; Lamping, K.G.; Duttaroy, A.; Zhang, W.; Cui, Y.; Bymaster, F.P.; McKinzie, D.L.; Felder, C.C.; Deng, C.X.; Faraci, F.M.; Wess, J. Cholinergic dilation of cerebral blood vessels is abolished in M(5) muscarinic acetylcholine receptor knockout mice. Proc. Natl. Acad. Sci. USA 2001, 98, 14096-14101.
18. Yamada, M.; Miyakawa, T.; Duttaroy, A.; Yamanaka, A.; Moriguchi, T.; Makita, R.; Ogawa, M.; Chou, C.J.; Xia, B.; Crawley, J.N.; Felder, C.C.; Deng, C.X.; Wess, J. Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature 2001, 410, 207-212.
19. Bymaster, F.P.; McKinzie, D.L.; Felder, C.C.; Wess, J. Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system. Neurochem. Res. 2003, 28, 437-442.
20. Kawashima, K.; Fujii, T. Basic and clinical aspects of non-neuronal acetylcholine: Overview of non-neuronal cholinergic systems and their biological significance. J. Pharmacol. Sci. 2008, 106, 167-173.
21. Kummer, W.; Lips, K.S.; Pfeil, U. The epithelial cholinergic system of the airways. Histochem. Cell Biol. 2008, 130, 219-234.
22. Wessler, I.; Kirkpatrick, C.J. Acetylcholine beyond neurons: The non-neuronal cholinergic system in humans. Br. J. Pharmacol. 2008, 154, 1558-1571.
23. Grando, S.A.; Crosby, A.M.; Zelickson, B.D.; Dahl, M.V. Agarose gel keratinocyte outgrowth system as a model of skin re-epithelization: requirement of endogenous acetylcholine for outgrowth initiation. J. Invest. Dermatol. 1993, 101, 804-810.
24. Grando, S.A.; Kist, D.A.; Qi, M.; Dahl, M.V. Human keratinocytes synthesize, secrete, and degrade acetylcholine. J. Invest. Dermatol. 1993, 101, 32-36.
25. Ndoye, A.; Buchli, R.; Greenberg, B.; Nguyen, V.T.; Zia, S.; Rodriguez, J.G.; Webber, R.J.; Lawry, M.A.; Grando, S.A. Identification and mapping of keratinocyte muscarinic acetylcholine receptor subtypes in human epidermis. J. Invest. Dermatol. 1998, 111, 410-416.
26. Buchli, R.; Ndoye, A.; Arredondo, J.; Webber, R.J.; Grando, S.A. Identification and characterization of muscarinic acetylcholine receptor subtypes expressed in human skin melanocytes. Mol. Cell. Biochem. 2001, 228, 57-72.
27. Chernyavsky, A.I.; Arredondo, J.; Wess, J.; Karlsson, E.; Grando, S.A. Novel signaling pathways mediating reciprocal control of keratinocyte migration and wound epithelialization through M3 and M4 muscarinic receptors. J. Cell. Biol. 2004, 166, 261-272.
28. Nguyen, V.T.; Ndoye, A.; Hall, L.L.; Zia, S.; Arredondo, J.; Chernyavsky, A.I.; Kist, D.A.; Zelickson, B.D.; Lawry, M.A.; Grando, S.A. Programmed cell death of keratinocytes culminates in apoptotic secretion of a humectant upon secretagogue action of acetylcholine. J. Cell. Sci. 2001, 114, 1189-1204.
29. Bschleipfer, T.; Schukowski, K.; Weidner, W.; Grando, S.A.; Schwantes, U.; Kummer, W.; Lips, K.S. Expression and distribution of cholinergic receptors in the human urothelium. Life Sci. 2007, 80, 2303-2307.
30. Chess-Williams, R.; Chapple, C.R.; Yamanishi, T.; Yasuda, K.; Sellers, D.J. The minor population of M3-receptors mediate contraction of human detrusor muscle in vitro. J. Auton. Pharmacol. 2001, 21, 243-248.
31. Metzen, J.; Bittinger, F.; Kirkpatrick, C.J.; Kilbinger, H.; Wessler, I. Proliferative effect of acetylcholine on rat trachea epithelial cells is mediated by nicotinic receptors and muscarinic receptors of the M1-subtype. Life Sci. 2003, 72, 2075-2080.
32. Acevedo, M. Effect of acetyl choline on ion transport in sheep tracheal epithelium. Pflugers Arch. 1994, 427, 543-546.
33. Klein, M.K.; Haberberger, R.V.; Hartmann, P.; Faulhammer, P.; Lips, K.S.; Krain, B.; Wess, J.; Kummer, W.; Konig, P. Muscarinic receptor subtypes in cilia-driven transport and airway epithelial development. Eur. Respir. J. 2009, 33, 1113-1121.
34. Kilbinger, H.; von Bardeleben, R.S.; Siefken, H.; Wolf, D. Prejunctional muscarinic receptors regulating neurotransmitter release in airways. Life Sci. 1995, 56, 981-987.
35. Wang, H.; Han, H.; Zhang, L.; Shi, H.; Schram, G.; Nattel, S.; Wang, Z. Expression of multiple subtypes of muscarinic receptors and cellular distribution in the human heart. Mol. Pharmacol. 2001, 59, 1029-1036.
36. Milner, P.; Kirkpatrick, K.A.; Ralevic, V.; Toothill, V.; Pearson, J.; Burnstock, G. Endothelial cells cultured from human umbilical vein release ATP, substance P and acetylcholine in response to increased flow. Proc. Biol. Sci. 1990, 241, 245-248.
37. Kawashima, K.; Fujii, T. Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front. Biosci. 2004, 9, 2063-2085.
38. Kawashima, K.; Yoshikawa, K.; Fujii, Y.X.; Moriwaki, Y.; Misawa, H. Expression and function of genes encoding cholinergic components in murine immune cells. Life Sci. 2007, 80, 2314-2319.
39. Qian, J.; Galitovskiy, V.; Chernyavsky, A.I.; Marchenko, S.; Grando, S.A. Plasticity of the murine spleen T-cell cholinergic receptors and their role in in vitro differentiation of naive CD4 T cells toward the Th1, Th2 and Th17 lineages. Genes Immun. 2011, 12, 222-230.
40. Fujii, T.; Watanabe, Y.; Inoue, T.; Kawashima, K. Upregulation of mRNA encoding the M5 muscarinic acetylcholine receptor in human T- and B-lymphocytes during immunological responses. Neurochemical. Res. 2003, 28, 423-429.
41. Kawashima, K.; Fujii, T.; Moriwaki, Y.; Misawa, H. Critical roles of acetylcholine and the muscarinic and nicotinic acetylcholine receptors in the regulation of immune function. Life Sci. 2012, 91, 1027-1032.
42. Duttaroy, A.; Zimliki, C.L.; Gautam, D.; Cui, Y.; Mears, D.; Wess, J. Muscarinic stimulation of pancreatic insulin and glucagon release is abolished in m3 muscarinic acetylcholine receptor-deficient mice. Diabetes 2004, 53, 1714-1720.
43. Horn, F.; van der Wenden, E.M.; Oliveira, L.; AP, I.J.; Vriend, G. Receptors coupling to G proteins: Is there a signal behind the sequence? Proteins 2000, 41, 448-459.
44. Albert, P.R.; Robillard, L. G protein specificity: traffic direction required. Cell Signal. 2002, 14, 407-418.
45. Rumenapp, U.; Asmus, M.; Schablowski, H.; Woznicki, M.; Han, L.; Jakobs, K.H.; Fahimi-Vahid, M.; Michalek, C.; Wieland, T.; Schmidt, M. The M3 muscarinic acetylcholine receptor expressed in HEK-293 cells signals to phospholipase D via G12 but not Gq-type G proteins: regulators of G proteins as tools to dissect pertussis toxin-resistant G proteins in receptor-effector coupling. J. Biol. Chem. 2001, 276, 2474-2479.
46. Meyer zu Heringdorf, D.; Lass, H.; Alemany, R.; Laser, K.T.; Neumann, E.; Zhang, C.; Schmidt, M.; Rauen, U.; Jakobs, K.H.; van Koppen, C.J. Sphingosine kinase-mediated Ca2+ signalling by G-protein-coupled receptors. EMBO J. 1998, 17, 2830-2837.
47. Neubig, R.R.; Siderovski, D.P. Regulators of G-protein signalling as new central nervous system drug targets. Nat. Rev. Drug Discov. 2002, 1, 187-197.
48. Logothetis, D.E.; Kurachi, Y.; Galper, J.; Neer, E.J.; Clapham, D.E. The beta gamma subunits of GTP-binding proteins activate the muscarinic K+ channel in heart. Nature 1987, 325, 321-326.
49. Jones, S.V. Modulation of the inwardly rectifying potassium channel IRK1 by the m1 muscarinic receptor. Mol. Pharmacol. 1996, 49, 662-667.
50. Jones, S.V. Muscarinic receptor subtypes: modulation of ion channels. Life Sci. 1993, 52, 457- 464.
51. Wickman, K.; Clapham, D.E. Ion channel regulation by G proteins. Physiol. Rev. 1995, 75, 865- 885.
52. Borroto-Escuela, D.O.; Agnati, L.F.; Fuxe, K.; Ciruela, F. Muscarinic acetylcholine receptorinteracting proteins (mAChRIPs): Targeting the receptorsome. Curr. Drug Targets 2012, 13, 53- 71.
53. Borroto-Escuela, D.O.; Correia, P.A.; Romero-Fernandez, W.; Narvaez, M.; Fuxe, K.; Ciruela, F.; Garriga, P. Muscarinic receptor family interacting proteins: role in receptor function. J. Neurosci. Meth. 2011, 195, 161-169.
54. Kim, J.Y.; Yang, M.S.; Oh, C.D.; Kim, K.T.; Ha, M.J.; Kang, S.S.; Chun, J.S. Signalling pathway leading to an activation of mitogen-activated protein kinase by stimulating M3 muscarinic receptor. Biochem. J. 1999, 337, 275-280.
55. Crespo, P.; Xu, N.; Daniotti, J.L.; Troppmair, J.; Rapp, U.R.; Gutkind, J.S. Signaling through transforming G protein-coupled receptors in NIH 3T3 cells involves c-Raf activation. Evidence for a protein kinase C-independent pathway. J. Biol. Chem. 1994, 269, 21103-21109.
56. Hawes, B.E.; van Biesen, T.; Koch, W.J.; Luttrell, L.M.; Lefkowitz, R.J. Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation. J. Biol. Chem. 1995, 270, 17148-17153.
57. Crespo, P.; Xu, N.; Simonds, W.F.; Gutkind, J.S. Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits. Nature 1994, 369, 418-420.
58. Rosenblum, K.; Futter, M.; Jones, M.; Hulme, E.C.; Bliss, T.V. ERKI/II regulation by the muscarinic acetylcholine receptors in neurons. J. Neurosci. 2000, 20, 977-985.
59. Berkeley, J.L.; Levey, A.I. Muscarinic activation of mitogen-activated protein kinase in PC12 cells. J. Neurochem. 2000, 75, 487-493.
60. van Biesen, T.; Hawes, B.E.; Raymond, J.R.; Luttrell, L.M.; Koch, W.J.; Lefkowitz, R.J. G(o)- protein alpha-subunits activate mitogen-activated protein kinase via a novel protein kinase C-dependent mechanism. J. Biol. Chem. 1996, 271, 1266-1269.
61. Lopez-Ilasaca, M.; Crespo, P.; Pellici, P.G.; Gutkind, J.S.; Wetzker, R. Linkage of G proteincoupled receptors to the MAPK signaling pathway through PI 3-kinase gamma. Science 1997, 275, 394-397.
62. Coso, O.A.; Teramoto, H.; Simonds, W.F.; Gutkind, J.S. Signaling from G protein-coupled receptors to c-Jun kinase involves beta gamma subunits of heterotrimeric G proteins acting on a Ras and Rac1-dependent pathway. J. Biol. Chem. 1996, 271, 3963-3966.
63. Nagao, M.; Yamauchi, J.; Kaziro, Y.; Itoh, H. Involvement of protein kinase C and Src family tyrosine kinase in Galphaq/11-induced activation of c-Jun N-terminal kinase and p38 mitogenactivated protein kinase. J. Biol. Chem. 1998, 273, 22892-22898.
64. Wylie, P.G.; Challiss, R.A.; Blank, J.L. Regulation of extracellular-signal regulated kinase and c-Jun N-terminal kinase by G-protein-linked muscarinic acetylcholine receptors. Biochem. J. 1999, 338, 619-628.
65. Yamauchi, J.; Nagao, M.; Kaziro, Y.; Itoh, H. Activation of p38 mitogen-activated protein kinase by signaling through G protein-coupled receptors. Involvement of Gbetagamma and Galphaq/11 subunits. J. Biol. Chem. 1997, 272, 27771-27777.
66. Hosey, M.M.; Benovic, J.L.; DebBurman, S.K.; Richardson, R.M. Multiple mechanisms involving protein phosphorylation are linked to desensitization of muscarinic receptors. Life Sci. 1995, 56, 951-955.
67. Pitcher, J.A.; Touhara, K.; Payne, E.S.; Lefkowitz, R.J. Pleckstrin homology domain-mediated membrane association and activation of the beta-adrenergic receptor kinase requires coordinate interaction with G beta gamma subunits and lipid. J. Biol. Chem. 1995, 270, 11707-11710.
68. Elorza, A.; Sarnago, S.; Mayor, F., Jr. Agonist-dependent modulation of G protein-coupled receptor kinase 2 by mitogen-activated protein kinases. Mol. Pharmacol. 2000, 57, 778-783.
69. Pitcher, J.A.; Tesmer, J.J.; Freeman, J.L.; Capel, W.D.; Stone, W.C.; Lefkowitz, R.J. Feedback inhibition of G protein-coupled receptor kinase 2 (GRK2) activity by extracellular signalregulated kinases. J. Biol. Chem. 1999, 274, 34531-34534.
70. Vogler, O.; Nolte, B.; Voss, M.; Schmidt, M.; Jakobs, K.H.; van Koppen, C.J. Regulation of muscarinic acetylcholine receptor sequestration and function by beta-arrestin. J. Biol. Chem. 1999, 274, 12333-12338.
71. Edwardson, J.M.; Szekeres, P.G. Endocytosis and recycling of muscarinic receptors. Life Sci. 1999, 64, 487-494.
72. van Koppen, C.J. Multiple pathways for the dynamin-regulated internalization of muscarinic acetylcholine receptors. Biochem. Soc. Trans. 2001, 29, 505-508.
73. Vogler, O.; Bogatkewitsch, G.S.; Wriske, C.; Krummenerl, P.; Jakobs, K.H.; van Koppen, C.J. Receptor subtype-specific regulation of muscarinic acetylcholine receptor sequestration by dynamin. Distinct sequestration of m2 receptors. J. Biol. Chem. 1998, 273, 12155-12160.
74. Haga, K.; Kruse, A.C.; Asada, H.; Yurugi-Kobayashi, T.; Shiroishi, M.; Zhang, C.; Weis, W.I.; Okada, T.; Kobilka, B.K.; Haga, T.; Kobayashi, T. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature 2012, 482, 547-551.
75. Ichiyama, S.; Oka, Y.; Haga, K.; Kojima, S.; Tateishi, Y.; Shirakawa, M.; Haga, T. The structure of the third intracellular loop of the muscarinic acetylcholine receptor M2 subtype. FEBS Lett. 2006, 580, 23-26.
76. Hawes, B.E.; Luttrell, L.M.; Exum, S.T.; Lefkowitz, R.J. Inhibition of G protein-coupled receptor signaling by expression of cytoplasmic domains of the receptor. J. Biol. Chem. 1994, 269, 15776-15785.
77. Schlador, M.L.; Grubbs, R.D.; Nathanson, N.M. Multiple topological domains mediate subtypespecific internalization of the M2 muscarinic acetylcholine receptor. J. Biol. Chem. 2000, 275, 23295-23302.
78. Tsuga, H.; Kameyama, K.; Haga, T.; Honma, T.; Lameh, J.; Sadee, W. Internalization and downregulation of human muscarinic acetylcholine receptor m2 subtypes. Role of third intracellular m2 loop and G protein-coupled receptor kinase 2. J. Biol. Chem. 1998, 273, 5323-5330.
79. Wu, G.; Bogatkevich, G.S.; Mukhin, Y.V.; Benovic, J.L.; Hildebrandt, J.D.; Lanier, S.M. Identification of Gbetagamma binding sites in the third intracellular loop of the M(3)-muscarinic receptor and their role in receptor regulation. J. Biol. Chem. 2000, 275, 9026-9034.
80. Michal, P.; Rudajev, V.; El-Fakahany, E.E.; Dolezal, V. Membrane cholesterol content influences binding properties of muscarinic M2 receptors and differentially impacts activation of second messenger pathways. Eur. J. Pharmacol. 2009, 606, 50-60.
81. Chmelar, R.S.; Nathanson, N.M. Identification of a novel apical sorting motif and mechanism of targeting of the M2 muscarinic acetylcholine receptor. J. Biol. Chem. 2006, 281, 35381-35396.
82. van Koppen, C.J.; Nathanson, N.M. Site-directed mutagenesis of the m2 muscarinic acetylcholine receptor. Analysis of the role of N-glycosylation in receptor expression and function. J. Biol. Chem. 1990, 265, 20887-20892.
83. Park, P.; Sum, C.S.; Hampson, D.R.; Van Tol, H.H.; Wells, J.W. Nature of the oligomers formed by muscarinic m2 acetylcholine receptors in Sf9 cells. Eur. J. Pharmacol. 2001, 421, 11-22.
84. Pisterzi, L.F.; Jansma, D.B.; Georgiou, J.; Woodside, M.J.; Chou, J.T.; Angers, S.; Raicu, V.; Wells, J.W. Oligomeric size of the m2 muscarinic receptor in live cells as determined by quantitative fluorescence resonance energy transfer. J. Biol. Chem. 2010, 285, 16723-16738.
85. Goin, J.C.; Nathanson, N.M. Quantitative analysis of muscarinic acetylcholine receptor homoand heterodimerization in live cells: regulation of receptor down-regulation by heterodimerization. J. Biol. Chem. 2006, 281, 5416-5425.
86. Maggio, R.; Barbier, P.; Fornai, F.; Corsini, G.U. Functional role of the third cytoplasmic loop in muscarinic receptor dimerization. J. Biol. Chem. 1996, 271, 31055-31060.
87. Michal, P.; El-Fakahany, E.E.; Dolezal, V. Muscarinic M2 receptors directly activate Gq/11 and Gs G-proteins. J. Pharmacol. Exp. Ther. 2007, 320, 607-614.
88. Mochizuki, N.; Ohba, Y.; Kiyokawa, E.; Kurata, T.; Murakami, T.; Ozaki, T.; Kitabatake, A.; Nagashima, K.; Matsuda, M. Activation of the ERK/MAPK pathway by an isoform of rap1GAP associated with G alpha(i). Nature 1999, 400, 891-894.
89. Daub, H.; Wallasch, C.; Lankenau, A.; Herrlich, A.; Ullrich, A. Signal characteristics of G protein-transactivated EGF receptor. EMBO J. 1997, 16, 7032-7044.
90. Gschwind, A.; Zwick, E.; Prenzel, N.; Leserer, M.; Ullrich, A. Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene 2001, 20, 1594-1600.
91. Prenzel, N.; Zwick, E.; Daub, H.; Leserer, M.; Abraham, R.; Wallasch, C.; Ullrich, A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999, 402, 884-888.
92. McCole, D.F.; Keely, S.J.; Coffey, R.J.; Barrett, K.E. Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth factor-alpha. J. Biol. Chem. 2002, 277, 42603-42612.
93. Tsai, W.; Morielli, A.D.; Peralta, E.G., The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity. EMBO J. 1997, 16, 4597-4605.
94. Stirnweiss, J.; Valkova, C.; Ziesche, E.; Drube, S.; Liebmann, C. Muscarinic M2 receptors mediate transactivation of EGF receptor through Fyn kinase and without matrix metalloproteases. Cell. Signal. 2006, 18, 1338-1349.
95. DeFea, K.A.; Zalevsky, J.; Thoma, M.S.; Dery, O.; Mullins, R.D.; Bunnett, N.W. beta-arrestindependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J. Cell. Biol 2000, 148, 1267-1281.
96. Tohgo, A.; Pierce, K.L.; Choy, E.W.; Lefkowitz, R.J.; Luttrell, L.M. beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J. Biol. Chem. 2002, 277, 9429-9436.
97. Jones, K.T.; Echeverry, M.; Mosser, V.A.; Gates, A.; Jackson, D.A. Agonist mediated internalization of M2 mAChR is beta-arrestin-dependent. J. Mol. Signal. 2006, 1, 7.
98. Pitcher, J.A.; Freedman, N.J.; Lefkowitz, R.J. G protein-coupled receptor kinases. Annu. Rev. Biochem. 1998, 67, 653-692.
99. Nakata, H.; Kameyama, K.; Haga, K.; Haga, T. Location of agonist-dependent-phosphorylation sites in the third intracellular loop of muscarinic acetylcholine receptors (m2 subtype). Eur. J. Biochem. 1994, 220, 29-36.
100. Pals-Rylaarsdam, R.; Xu, Y.; Witt-Enderby, P.; Benovic, J.L.; Hosey, M.M. Desensitization and internalization of the m2 muscarinic acetylcholine receptor are directed by independent mechanisms. J. Biol. Chem. 1995, 270, 29004-29011.
101. Pals-Rylaarsdam, R.; Gurevich, V.V.; Lee, K.B.; Ptasienski, J.A.; Benovic, J.L.; Hosey, M.M. Internalization of the m2 muscarinic acetylcholine receptor. Arrestin-independent and -dependent pathways. J. Biol. Chem. 1997, 272, 23682-23689.
102. Lee, K.B.; Ptasienski, J.A.; Bunemann, M.; Hosey, M.M. Acidic amino acids flanking phosphorylation sites in the M2 muscarinic receptor regulate receptor phosphorylation, internalization, and interaction with arrestins. J. Biol. Chem. 2000, 275, 35767-35777.
103. Lee, K.B.; Ptasienski, J.A.; Pals-Rylaarsdam, R.; Gurevich, V.V.; Hosey, M.M. Arrestin binding to the M(2) muscarinic acetylcholine receptor is precluded by an inhibitory element in the third intracellular loop of the receptor. J. Biol. Chem. 2000, 275, 9284-9289.
104. Krueger, K.M.; Daaka, Y.; Pitcher, J.A.; Lefkowitz, R.J. The role of sequestration in G proteincoupled receptor resensitization. Regulation of beta2-adrenergic receptor dephosphorylation by vesicular acidification. J. Biol. Chem. 1997, 272, 5-8.
105. Thangaraju, A.; Sawyer, G.W. Comparison of the kinetics and extent of muscarinic M1-M5 receptor internalization, recycling and downregulation in Chinese hamster ovary cells. Eur. J. Pharmacol. 2011, 650, 534-543.
106. Roseberry, A.G.; Hosey, M.M. Trafficking of M(2) muscarinic acetylcholine receptors. J. Biol. Chem. 1999, 274, 33671-33676.
107. Feron, O.; Smith, T.W.; Michel, T.; Kelly, R.A. Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes. J. Biol. Chem. 1997, 272, 17744-17748.
108. Roseberry, A.G.; Hosey, M.M. Internalization of the M2 muscarinic acetylcholine receptor proceeds through an atypical pathway in HEK293 cells that is independent of clathrin and caveolae. J. Cell. Sci 2001, 114, 739-746.
109. Delaney, K.A.; Murph, M.M.; Brown, L.M.; Radhakrishna, H. Transfer of M2 muscarinic acetylcholine receptors to clathrin-derived early endosomes following clathrin-independent endocytosis. J. Biol. Chem. 2002, 277, 33439-33446.
110. Reiner, C.; Nathanson, N.M. The internalization of the M2 and M4 muscarinic acetylcholine receptors involves distinct subsets of small G-proteins. Life Sci. 2008, 82, 718-727.
111. Ferguson, S.M.; De Camilli, P. Dynamin, a membrane-remodelling GTPase. Nat. Rev. Mol. Cell Biol. 2012, 13, 75-88.
112. Macia, E.; Ehrlich, M.; Massol, R.; Boucrot, E.; Brunner, C.; Kirchhausen, T. Dynasore, a cellpermeable inhibitor of dynamin. Dev. Cell 2006, 10, 839-850.
113. Mosser, V.A.; Jones, K.T.; Hoffman, K.M.; McCarty, N.A.; Jackson, D.A. Differential role of beta-arrestin ubiquitination in agonist-promoted down-regulation of M1 vs M2 muscarinic acetylcholine receptors. J. Mol. Signal. 2008, 3, 20.
114. Reiner, C.L.; McCullar, J.S.; Kow, R.L.; Le, J.H.; Goodlett, D.R.; Nathanson, N.M. RACK1 associates with muscarinic receptors and regulates M(2) receptor trafficking. PLoS One 2010, 5, e13517.
115. Bolger, G.B.; Baillie, G.S.; Li, X.; Lynch, M.J.; Herzyk, P.; Mohamed, A.; Mitchell, L.H.; McCahill, A.; Hundsrucker, C.; Klussmann, E.; Adams, D.R.; Houslay, M.D. Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, beta-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5. Biochem. J. 2006, 398, 23-36.
116. Wennerberg, K.; Rossman, K.L.; Der, C.J. The Ras superfamily at a glance. J. Cell. Sci. 2005, 118, 843-846.
117. Donaldson, J.G. Multiple roles for Arf6: Sorting, structuring, and signaling at the plasma membrane. J. Biol. Chem. 2003, 278, 41573-41576.
118. Donaldson, J.G.; Jackson, C.L. ARF family G proteins and their regulators: roles in membrane transport, development and disease. Nat. Rev. Mol. Cell Biol. 2010, 12, 362-375.
119. Donaldson, J.G.; Honda, A. Localization and function of Arf family GTPases. Biochem. Soc. Trans. 2005, 33, 639-642.
120. Boman, A.L.; Taylor, T.C.; Melancon, P.; Wilson, K.L. A role for ADP-ribosylation factor in nuclear vesicle dynamics. Nature 1992, 358, 512-514.
121. Dascher, C.; Balch, W.E. Dominant inhibitory mutants of ARF1 block endoplasmic reticulum to Golgi transport and trigger disassembly of the Golgi apparatus. J. Biol. Chem. 1994, 269, 1437-1448.
122. Lenhard, J.M.; Kahn, R.A.; Stahl, P.D. Evidence for ADP-ribosylation factor (ARF) as a regulator of in vitro endosome-endosome fusion. J. Biol. Chem. 1992, 267, 13047-13052.
123. Taylor, T.C.; Kahn, R.A.; Melancon, P. Two distinct members of the ADP-ribosylation factor family of GTP-binding proteins regulate cell-free intra-Golgi transport. Cell 1992, 70, 69-79.
124. D'Souza-Schorey, C.; Li, G.; Colombo, M.I.; Stahl, P.D. A regulatory role for ARF6 in receptor-mediated endocytosis. Science 1995, 267, 1175-1178.
125. Sabe, H. Requirement for Arf6 in cell adhesion, migration, and cancer cell invasion. J. Biochem. 2003, 134, 485-489.
126. D'Souza-Schorey, C.; Boshans, R.L.; McDonough, M.; Stahl, P.D.; Van Aelst, L. A role for POR1, a Rac1-interacting protein, in ARF6-mediated cytoskeletal rearrangements. Embo. J. 1997, 16, 5445-5454.
127. Radhakrishna, H.; Klausner, R.D.; Donaldson, J.G. Aluminum fluoride stimulates surface protrusions in cells overexpressing the ARF6 GTPase. J. Cell. Biol. 1996, 134, 935-947.
128. Brown, F.D.; Rozelle, A.L.; Yin, H.L.; Balla, T.; Donaldson, J.G. Phosphatidylinositol 4,5- bisphosphate and Arf6-regulated membrane traffic. J. Cell Biol 2001, 154, 1007-1017.
129. Franco, M.; Chardin, P.; Chabre, M.; Paris, S. Myristoylation of ADP-ribosylation factor 1 facilitates nucleotide exchange at physiological Mg2+ levels. J. Biol. Chem. 1995, 270, 1337-1341.
130. Zhang, Q.; Cox, D.; Tseng, C.C.; Donaldson, J.G.; Greenberg, S. A requirement for ARF6 in Fcgamma receptor-mediated phagocytosis in macrophages. J. Biol. Chem. 1998, 273, 19977-19981.
131. Caumont, A.S.; Galas, M.C.; Vitale, N.; Aunis, D.; Bader, M.F. Regulated exocytosis in chromaffin cells. Translocation of ARF6 stimulates a plasma membrane-associated phospholipase D. J. Biol. Chem. 1998, 273, 1373-1379.
132. D'Souza-Schorey, C. Disassembling adherens junctions: breaking up is hard to do. Trends Cell. Biol 2005, 15, 19-26.
133. Palacios, F.; D'Souza-Schorey, C. Modulation of Rac1 and ARF6 activation during epithelial cell scattering. J. Biol. Chem. 2003, 278, 17395-17400.
134. Palacios, F.; Schweitzer, J.K.; Boshans, R.L.; D'Souza-Schorey, C. ARF6-GTP recruits Nm23- H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly. Nat. Cell Biol. 2002, 4, 929-936.
135. Martin, T.F. PI(4,5)P(2) regulation of surface membrane traffic. Curr. Opin. Cell Biol. 2001, 13, 493-499.
136. Wenk, M.R.; De Camilli, P. Protein-lipid interactions and phosphoinositide metabolism in membrane traffic: insights from vesicle recycling in nerve terminals. Proc. Natl. Acad. Sci. USA 2004, 101, 8262-8269.
137. Powelka, A.M.; Sun, J.; Li, J.; Gao, M.; Shaw, L.M.; Sonnenberg, A.; Hsu, V.W. Stimulationdependent recycling of integrin beta1 regulated by ARF6 and Rab11. Traffic 2004, 5, 20-36.
138. Radhakrishna, H.; Donaldson, J.G. ADP-ribosylation factor 6 regulates a novel plasma membrane recycling pathway. J. Cell. Biol. 1997, 139, 49-61.
139. Franco, M.; Peters, P.J.; Boretto, J.; van Donselaar, E.; Neri, A.; D'Souza-Schorey, C.; Chavrier, P. EFA6, a sec7 domain-containing exchange factor for ARF6, coordinates membrane recycling and actin cytoskeleton organization. Embo. J. 1999, 18, 1480-1491.
140. Houndolo, T.; Boulay, P.L.; Claing, A. G protein-coupled receptor endocytosis in ADPribosylation factor 6-depleted cells. J. Biol. Chem. 2005, 280, 5598-5604.
141. Lau, A.W.; Chou, M.M. The adaptor complex AP-2 regulates post-endocytic trafficking through the non-clathrin Arf6-dependent endocytic pathway. J. Cell. Sci. 2008, 121, 4008-4017.
142. Hein, L.; Ishii, K.; Coughlin, S.R.; Kobilka, B.K. Intracellular targeting and trafficking of thrombin receptors. A novel mechanism for resensitization of a G protein-coupled receptor. J. Biol. Chem. 1994, 269, 27719-27726.
143. Pierce, K.L.; Luttrell, L.M.; Lefkowitz, R.J. New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene 2001, 20, 1532-1539.
144. Tong, H.; Rockman, H.A.; Koch, W.J.; Steenbergen, C.; Murphy, E. G protein-coupled receptor internalization signaling is required for cardioprotection in ischemic preconditioning. Circ. Res. 2004, 94, 1133-1141.
145. Premont, R.T.; Claing, A.; Vitale, N.; Freeman, J.L.; Pitcher, J.A.; Patton, W.A.; Moss, J.; Vaughan, M.; Lefkowitz, R.J. beta2-Adrenergic receptor regulation by GIT1, a G protein- coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein. Proc. Natl. Acad. Sci. USA 1998, 95, 14082-14087.
146. Claing, A.; Chen, W.; Miller, W.E.; Vitale, N.; Moss, J.; Premont, R.T.; Lefkowitz, R.J. beta- Arrestin-mediated ADP-ribosylation factor 6 activation and beta 2-adrenergic receptor endocytosis. J. Biol. Chem. 2001, 276, 42509-42513.
147. Claing, A.; Laporte, S.A.; Caron, M.G.; Lefkowitz, R.J. Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins. Prog. Neurobiol. 2002, 66, 61-79.
148. Madziva, M.T.; Birnbaumer, M. A role for ADP-ribosylation factor 6 in the processing of G-protein-coupled receptors. J. Biol. Chem. 2006, 281, 12178-12186.
149. Weigert, R.; Yeung, A.C.; Li, J.; Donaldson, J.G. Rab22a regulates the recycling of membrane proteins internalized independently of clathrin. Mol. Biol. Cell. 2004, 15, 3758-3770.
150. Wallukat, G.; Nissen, E.; Morwinski, R.; Muller, J. Autoantibodies against the beta- and muscarinic receptors in cardiomyopathy. Herz 2000, 25, 261-266.
151. Nussinovitch, U.; Shoenfeld, Y. The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies. Clin. Rev. Allergy Immunol. 2012, 42, 298-308.
152. Beltrame, S.P.; Auger, S.R.; Bilder, C.R.; Waldner, C.I.; Goin, J.C. Modulation of M(2) muscarinic receptor-receptor interaction by immunoglobulin G antibodies from Chagas' disease patients. Clin. Exp. Immunol. 2011, 164, 170-179.
153. Leiros, C.P.; Sterin-Borda, L.; Borda, E.S.; Goin, J.C.; Hosey, M.M. Desensitization and sequestration of human m2 muscarinic acetylcholine receptors by autoantibodies from patients with Chagas' disease. J. Biol. Chem. 1997, 272, 12989-12993.
154. Fox, R.I.; Stern, M.; Michelson, P. Update in Sjogren syndrome. Curr. Opin. Rheumatol. 2000, 12, 391-398.
155. He, J.; Qiang, L.; Ding, Y.; Wei, P.; Li, Y.N.; Hua, H.; Li, Z.G. The role of muscarinic acetylcholine receptor type 3 polypeptide (M3RP205-220) antibody in the saliva of patients with primary Sjogren's syndrome. Clin. Exp. Rheumatol. 2012, 30, 322-326.
156. Jin, M.; Hwang, S.M.; Davies, A.J.; Shin, Y.; Bae, J.S.; Lee, J.H.; Lee, E.B.; Song, Y.W.; Park, K. Autoantibodies in primary Sjogren's syndrome patients induce internalization of muscarinic type 3 receptors. Biochimica et biophysica acta 2012, 1822, 161-167.
157. Bjur, D.; Danielson, P.; Alfredson, H.; Forsgren, S. Presence of a non-neuronal cholinergic system and occurrence of up- and down-regulation in expression of M2 muscarinic acetylcholine receptors: new aspects of importance regarding Achilles tendon tendinosis (tendinopathy). Cell Tissue Res. 2008, 331, 385-400.
158. Fisher, J.T.; Vincent, S.G.; Gomeza, J.; Yamada, M.; Wess, J. Loss of vagally mediated bradycardia and bronchoconstriction in mice lacking M2 or M3 muscarinic acetylcholine receptors. FASEB J. 2004, 18, 711-713.
159. Jimenez, E.; Montiel, M. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells. J. Cell. Physiol. 2005, 204, 678-686.
160. Parnell, E.A.; Calleja-Macias, I.E.; Kalantari, M.; Grando, S.A.; Bernard, H.U. Muscarinic cholinergic signaling in cervical cancer cells affects cell motility via ERK1/2 signaling. Life Sci. 2012, 91, 1093-1098.
161. Fiszman, G.L.; Middonno, M.C.; de la Torre, E.; Farina, M.; Espanol, A.J.; Sales, M.E. Activation of muscarinic cholinergic receptors induces MCF-7 cells proliferation and angiogenesis by stimulating nitric oxide synthase activity. Cancer Biol. Ther. 2007, 6, 1106-1113.
162. Frucht, H.; Jensen, R.T.; Dexter, D.; Yang, W.L.; Xiao, Y. Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic
163. Cheng, K.; Zimniak, P.; Raufman, J.P. Transactivation of the epidermal growth factor receptor mediates cholinergic agonist-induced proliferation of H508 human colon cancer cells. Cancer Res. 2003, 63, 6744-6750.
164. Xie, G.; Cheng, K.; Shant, J.; Raufman, J.P. Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells. Am. J. Physiol. Gastrointest Liver Physiol. 2009, 296, G755-G763.
165. Ferretti, M.; Fabbiano, C.; Di Bari, M.; Ponti, D.; Calogero, A.; Tata, A.M. M2 muscarinic receptors inhibit cell proliferation in human glioblastoma cell lines. Life Sci. 2012, 91, 1134-1137.
166. Fucile, S.; Napolitano, M.; Mattei, E. Cholinergic stimulation of human microcytoma cell line H69. Biochem. Biophys. Res. Commun. 1997, 230, 501-504.
167. Williams, C.L.; Lennon, V.A. Activation of muscarinic acetylcholine receptors inhibits cell cycle progression of small cell lung carcinoma. Cell Regul. 1991, 2, 373-381.
168. Zhao, Y.; Wang, X.; Wang, T.; Hu, X.; Hui, X.; Yan, M.; Gao, Q.; Chen, T.; Li, J.; Yao, M.; Wan, D.; Gu, J.; Fan, J.; He, X. Acetylcholinesterase, a key prognostic predictor for hepatocellular carcinoma, suppresses cell growth and induces chemosensitization. Hepatology 2011, 53, 493-503.
169. Wess, J.; Duttaroy, A.; Zhang, W.; Gomeza, J.; Cui, Y.; Miyakawa, T.; Bymaster, F.P.; McKinzie, L.; Felder, C.C.; Lamping, K.G.; Faraci, F.M.; Deng, C.; Yamada, M. M1-M5 muscarinic receptor knockout mice as novel tools to study the physiological roles of the muscarinic cholinergic system. Recept. Channels 2003, 9, 279-290.
170. Ito, Y.; Oyunzul, L.; Seki, M.; Fujino Oki, T.; Matsui, M.; Yamada, S. Quantitative analysis of the loss of muscarinic receptors in various peripheral tissues in M1-M5 receptor single knockout mice. Br. J. Pharmacol. 2009, 156, 1147-1153.